Other Briefings
China Opens Doors to Foreign Investment in Cell Therapy and Wholly Foreign-Owned Hospitals in Pilot Cities
China has initiated a new round of foreign investment relaxation pilots in selected cities, permitting foreign investment in cell and gene therapy as well as wholly foreign-owned hospitals.
Asia Transfer Pricing Brief: Q2 2024
In our Asia Transfer Pricing Brief for Q2 2024, we present the latest updates and new guidelines on transfer pricing from Malaysia, Singapore, and the OECD.
Beijing Releases Negative List to Facilitate Data Export in Free Trade Zone
The Beijing FTZ has released its first data negative list outlining the types of data that must undergo export compliance procedures, providing much-needed clarity for companies.
How Swedish Companies Navigate China’s Evolving Market with Strategic Localization and Diversification
A recent white paper reflects that Swedish companies are navigating the complexities of the Chinese market by adopting “China-for-China” strategies while also exploring opportunities in other Asia-Pacific countries.
China Monthly Tax Brief: August 2024
In this monthly China tax brief for August 2024, we spotlight policies and measures just announced or scheduled for implementation.
China’s State Council Passes Key Data Security Regulations
A new draft regulation strengthens China’s cybersecurity and data protection framework. We look at what the document says.
Exploring China’s Leading AI Hubs: A Regional Analysis
In this article, we explore the distinct opportunities and strategic advantages offered by China’s key AI hubs, highlighting their roles in shaping the future of China’s AI industry landscape.
China’s New Quality Productive Forces: An Explainer
An emphasis on new quality productive forces in government policy in 2024 signals a major shift to an innovation-led economic growth model, presenting various opportunities in the sci-tech space.
